Literature DB >> 3146592

Electromechanical uncoupling in a molluscan muscle examined by the sucrose gap technique. The effect of calcium antagonist and agonist agents.

H Huddart1, R B Hill.   

Abstract

Membrane potential and tension of Busycon radular protractor muscles were studied by sucrose gap methods. Excitation-contraction (EC) coupling was examined in response to acetylcholine (ACh) and high K which depolarized the fibres and induced tension, but without action potential firing. Potassium depolarization did not follow predictions expected from the Nernst equation at low and very high K levels, and maximum tension was found at about 100 mM K. EC coupling was very sensitive to [Ca]0. Ca-free media eliminated K- and ACh-induced tension but with normal depolarization, showing full electromechanical uncoupling. Ionophore A23187 enhanced K- and ACh-induced responses and X-537A enhanced ACh responses, demonstrating acute dependence of activation on [Ca]0 in this muscle. The calcium antagonists nifedipine and nisoldipine reduced tension in the muscle only at very high concentrations, and both agents slightly reduced K- and ACh-induced depolarization. Verapamil reduced K- and ACh-induced tension but paradoxically it enhanced the depolarizing actions of these agents leading to electromechanical uncoupling. Abscisic acid (ABA) enhanced ACh- and K-induced tension and simultaneously enhanced their depolarizing actions. Ionophores and ABA appear to enhance calcium influx which may secondarily influence sodium influx. Calcium antagonists have no consistent actions on this muscle, suggesting that calcium channel activity of the radular protractor may be different from that seen in mammalian visceral muscles.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3146592     DOI: 10.1007/bf00691148

Source DB:  PubMed          Journal:  J Comp Physiol B        ISSN: 0174-1578            Impact factor:   2.200


  27 in total

1.  Effect of acetylcholine and high external potassium ions on 45Ca movements in molluscan smooth muscle.

Authors:  T Tameyasu; H Sugi
Journal:  Comp Biochem Physiol C Comp Pharmacol       Date:  1976

Review 2.  Aspects of smooth muscle function in molluscan catch muscle.

Authors:  B M Twarog
Journal:  Physiol Rev       Date:  1976-10       Impact factor: 37.312

3.  Calcium uptake by a subcellular membrane fraction of anterior byssus retractor muscle.

Authors:  M A Gogjian; E Bloomquist
Journal:  Comp Biochem Physiol C Comp Pharmacol       Date:  1977

4.  Voltage and time dependency of calcium mediated phasic and tonic responses in rat vas deferens smooth muscle--the effect of some calcium agonist and antagonist agents.

Authors:  P D Langton; H Huddart
Journal:  Gen Pharmacol       Date:  1988

5.  Ultrastructure of the radula protractor of Busycon canaliculatum. Sarcolemmic tubules and sarcoplasmic reticulum.

Authors:  J W Sanger; R B Hill
Journal:  Z Zellforsch Mikrosk Anat       Date:  1972

6.  Molluscan visceral muscle fine structure. General structure and sarcolemmal organization in the smooth muscle of the intestinal wall of Buccinum undatum L.

Authors:  S Hunt
Journal:  Tissue Cell       Date:  1981       Impact factor: 2.466

7.  Use of an ionophore to maintain repeated caffeine contractures in holothurian muscle.

Authors:  R B Hill
Journal:  Life Sci       Date:  1980-11-24       Impact factor: 5.037

8.  "Calcium-induced release of calcium" in rectal smooth muscle of mice.

Authors:  J T Cheng
Journal:  Jpn J Pharmacol       Date:  1976-02

9.  Molecular pharmacology of the calcium channel: evidence for subtypes, multiple drug-receptor sites, channel subunits, and the development of a radioiodinated 1,4-dihydropyridine calcium channel label, [125I]iodipine.

Authors:  H Glossmann; D R Ferry; A Goll; M Rombusch
Journal:  J Cardiovasc Pharmacol       Date:  1984       Impact factor: 3.105

10.  The effects of papaverine on the electrical and mechanical activity of the guinea-pig ureter.

Authors:  A F Brading; T V Burdyga; Z D Scripnyuk
Journal:  J Physiol       Date:  1983-01       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.